NACDS President and CEO Steven C. Anderson released the following statement today following the introduction of pharmacy benefit manager (PBM) reform legislation (HB 1509/SB 1550) in the Florida legislature:
Pharmacy benefit manager (PBM) reform; comprehensive direct and indirect remuneration (DIR) fee reform; and sustaining patient access to vaccinations, testing, and treatment among key topics at the February 28-March 1 program.
U.S. House Oversight and Accountability Committee expands bipartisan Congressional push to stop pharmaceutical benefit manipulation by middlemen.
Statement reflects “NACDS 2023” focus on adding value to NACDS members’ innovation of health and wellness in the pharmacy and beyond.
Call on SAMHSA to help ensure that the regulatory framework for medications for opioid use disorder treatment continues to accommodate evolving practice models that deliver treatment services in new and innovative ways – and in different patient care settings.
Dinner’s new venue in 25th Anniversary year will continue to build visibility and engagement for the NACDS Foundation’s focus on “cultivating innovation in care”.
Statement outlines specific solutions to patient-manipulation by “PBMs”.
NACDS stands up for seniors and pharmacies in comments on Medicare proposed rule.
NACDS President and CEO Steven C. Anderson issued the following statement, upon the release of a U.S. Department of Health and Human Services (HHS) Fact Sheet describing decision-making underway about implications of the May 11, 2023, expiration of the current Public Health Emergency (PHE).
While we all want to move on from COVID-19, doing so should not mean leaving behind millions of Americans who have relied on their trusted, local pharmacies for testing, vaccinations, and care during the pandemic.
